Immunocore Holdings plc (IMCR)

NASDAQ: IMCR · IEX Real-Time Price · USD

55.68

+0.94 (1.72%)

Apr 19, 2024, 4:00 PM EDT - Market closed

Immunocore Holdings Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-55.29	-52.54	-180.03	-92.62	-129.91	-89.54
Depreciation & Amortization	5.74	7.41	9.67	11.22	11.52	8.38
Share-Based Compensation	32.47	32.89	48.89	10.2	3.82	0.83
Other Operating Activities	20.02	-36.97	-21.64	-55.74	-30.9	58.67
Operating Cash Flow	2.94	-49.21	-143.11	-126.94	-145.48	-21.65
Capital Expenditures	-5.43	-2.2	-1.28	-3	-5	-4.36
Change in Investments	0	0	0	0.47	0.07	34.31
Other Investing Activities	-	-	-	3.96	1.66	42.56
Investing Cash Flow	-5.43	-2.2	-1.28	1.43	-3.27	72.52
Share Issuance / Repurchase	34.35	149.21	288.19	103.89	73.95	0.13
Debt Issued / Paid	0	-3.77	0	41.03	-5.05	0
Financing Cash Flow	34.35	145.44	288.19	144.93	68.91	0.13
Net Cash Flow	31.86	94.04	143.8	69.79	-62.98	51.86
Free Cash Flow	-2.49	-51.41	-144.39	-129.94	-150.47	-26.01
Free Cash Flow Margin	-1.00%	-29.48%	-395.75%	-345.18%	-468.97%	-87.96%
Free Cash Flow Per Share	-0.05	-1.12	-3.40	-3.19	-3.69	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).